+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena



The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena



Critical Reviews in Oncology/Hematology 131: 76-82



LncRNAs, as new players in the old battle against cancer, are significant components of gene regulatory networks. Mitochondria-associated lncRNAs have newly been discovered to work in concert with transcription factors and epigenetic regulators to modulate mitochondrial gene expression and mitochondrial function. Many mitochondria-associated lncRNAs regulate mitochondrial biosynthesis, bioenergetics, apoptosis and possibly govern the cross-talk of mitochondria with nuclei. The complexity of mitochondria-associated lncRNAs is now just starting to envisage. In this review, we collected available evidence that reinforces the importance of mitochondria-associated lncRNA in cancer metabolism, apoptosis, and cell senescence. For the non-exhaustive list of mitochondria-associated lncRNAs, we identified 18 lncRNAs in total (mitochondria-encoded lncRNAs or nuclei encoded mitochondria function associated lncRNAs) as emerging new players in cancer mitochondrial function. As lncRNAs exhibit cancer-type-specific expression patterns, they are attractive targets for selective therapeutic interventions. Manipulation of their function may thus represent a valuable strategy for future cancer treatment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065940304

Download citation: RISBibTeXText

PMID: 30293709

DOI: 10.1016/j.critrevonc.2018.08.005


Related references

Long noncoding RNAs coordinate functions between mitochondria and the nucleus. Epigenetics and Chromatin 10(1): 41, 2017

Long noncoding RNAs: novel players in colorectal cancer. Cancer Letters 361(1): 13-21, 2015

Long noncoding RNAs: new players in prostate cancer. Cancer Letters 339(1): 8, 2013

Dysfunctions of mitochondria in close association with strong perturbation of long noncoding RNAs expression in down syndrome. International Journal of Biochemistry and Cell Biology 92: 115-120, 2017

Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocrine-Related Cancer 25(2): R59-R82, 2018

From Heterochromatin to Long Noncoding RNAs in Drosophila: Expanding the Arena of Gene Function and Regulation. Advances in Experimental Medicine and Biology 1008: 75, 2017

Long Noncoding RNAs: Emerging Players in Medulloblastoma. Frontiers in Pediatrics 7: 67, 2019

Long noncoding RNAs in DNA methylation: new players stepping into the old game. Cell and Bioscience 6: 45, 2016

Long Noncoding RNAs: New Players in Ischaemia-Reperfusion Injury. Heart Lung and Circulation 27(3): 322-332, 2018

Methods for distinguishing between protein-coding and long noncoding RNAs and the elusive biological purpose of translation of long noncoding RNAs. Biochimica et Biophysica Acta 1859(1): 31-40, 2016

Long noncoding RNAs could be potential key players in the pathophysiology of Sjögren's syndrome. International Journal of Rheumatic Diseases 18(8): 898-905, 2015

Long noncoding RNAs, emerging players in muscle differentiation and disease. Skeletal Muscle 4(1): 8, 2014

Long noncoding RNAs: versatile players in biologcial processes and human disorders. Epigenomics 6(4): 375-379, 2014

Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells. Stem Cells and Development 22(16): 2240-2253, 2013

Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization. Theranostics 7(12): 3155-3167, 2017